Lee Ainslie Day One Biopharmaceuticals, Inc. Put Options Transaction History
Maverick Capital LTD
- $5.04 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$88.6 Million13.29% of portfolio
-
Black Rock Inc. New York, NY5.03MShares$69.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$65.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$52.5 Million0.02% of portfolio
-
State Street Corp Boston, MA2.89MShares$39.9 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.01B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...